Management of Dyslipidemia
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Management of Dyslipidemia
-
Narrated by:
-
By:
Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of global mortality and is strongly associated with cumulative exposure to atherogenic lipoproteins across the lifespan. Author Amber E. Johnson, MD, MS, MBA, of the University of Chicago joins JAMA Senior Editor Philip Greenland, MD, to discuss the ACC/AHA guideline on management of dyslipidemia.
Related Content:
- Dyslipidemia Evaluation and Management
- Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin Therapy
adbl_web_anon_alc_button_suppression_t1
No reviews yet